Global Synthetic Biology in Healthcare Market Size

The synthetic biology in healthcare market is estimated to grow from USD 9.4 billion in 2024 to reach USD 11.3 billion in 2025 and USD 88.2 billion by 2040, representing a CAGR of 14.7% during the forecast period.

Global Synthetic Biology in Healthcare Market Landscape

See What’s in the Full Report - Request Your Complimentary Insights!

Synthetic biology involves engineering of biological systems using advanced molecular technologies and tools for developing medicines and other bio-based products. It enables the development of custom-designed organisms, empowering pharmaceutical industries for designing therapeutic vaccines, semi-synthetic drugs and understanding disease mechanisms.

Click On The Thumbnails To View The Full Image

Synthetic Biology in Healthcare Market Services Providers

Synthetic Biology in Healthcare Market Distribution by Type of Product

Synthetic Biology in Healthcare Market Megatrends Analysis

Synthetic biology rapidly expands its utility by leveraging advanced technologies, such as DNA read, write and edit tools to make valuable products. Yet, the field is overcoming barriers in scaling sustainable processes and precision engineering, while still facing challenges of cost efficiency, regulatory acceptance, and integration into established industrial ecosystems.

Click On The Thumbnails To View The Full Image

Synthetic Biology in Healthcare Market Forces Analysis

Synthetic Biology in Healthcare Market Market Impact Analysis

Synthetic Biology in Healthcare Market Distribution by Type of Technology

The demand for synthetic biology has significantly increased in pharmaceutical industry, biotechnology industry, and agriculture and environmental sectors. Additionally, the growing shift towards biofuel or green fuel and sustainable packaging / biodegradable products are further contributing to the market growth. As synthetic biology technologies increasingly mature across various industrial sectors, they are likely to pave the way for manufacturing sustainable bio-based solutions.

Click On The Thumbnails To View The Full Image

Synthetic Biology in Healthcare Market Opportunity Analysis

Synthetic Biology in Healthcare Market Geographical Regions

Synthetic Biology in Healthcare Market Segment

Synthetic Biology in Healthcare Market: Report Attributes

Key Report Attributes	Details
Historical Trend	Since 2020
Forecast Period	Till 2040
Market Size 2025	$ 11.3 Billion
Market Size 2040	$ 88.2 Billion
CAGR (Till 2040)	14.7%

The market analysis highlights the likely distribution of current and forecasted opportunities in the synthetic biology in healthcare domain across various segments, including technology type, product type, application type, end-user, and geographical regions.

We have created three synthetic biology in healthcare market forecast scenarios focused on healthcare industry, conservative, base and optimistic, to account for future uncertainties in key parameters and enhance the robustness of our model. These scenarios represent different tracks of the industry's evolution.

Recent Developments in Synthetic Biology in Healthcare Market

Several recent developments in the field of synthetic biology have occurred, and we outline some of these below. These developments, even if they occurred after our market report’s release, reinforce the overall synthetic biology in healthcare market trends outlined in our analysis.

In January 2025, Camena Bioscience and Constructive Bio joined a collaborative project led by the Max-Planck Institute to develop synthetic chloroplast genomes, aiming to overcome technical challenges in DNA synthesis and assembly.
In January 2025, Twist Bioscience entered into a revised partnership with Ginkgo Bioworks to advance long DNA technology, enhance Twist’s synthesis capabilities, and strengthen collaboration in synthetic biology innovation across multiple industries.
In January 2025, Esphera SynBio secured USD 2 million in seed funding to advance its synthetic biology platform, which engineers cells to express proprietary transgenes that generate therapeutic exosomes as nanomedicine vaccines targeting cancer and infectious diseases.

Advances in Laboratory-Based Human Embryo Models

The field of synthetic biology and stem cell research continues to evolve rapidly, with researchers now capable of generating live embryos in the laboratory using pluripotent stem cells or engineered platforms that bypass conventional fertilization. One major breakthrough is the development of synthetic embryo models, also called “embryoids,” which self-organize into structures mimicking early mammalian development. Notably, teams at the Weizmann Institute and University of Cambridge have created embryo-like entities encompassing essential features, such as a beating heart, brain foundations, and extraembryonic tissues, grown entirely outside the womb for up to 14 days. These models, fabricated solely from stem cells, provide exquisite insight into human implantation and early pregnancy processes by replicating peri-implantation events and extraembryonic interactions.

Synthetic Biology in Healthcare Market Segmentation Insights

The market research report presents an in-depth analysis of the top synthetic biology companies, across different segments, as defined in the table below:

Synthetic Biology in Healthcare Market: Market Segmentation

Market Segmentation	Details
Type of Technology	PCR Technologies NGS Technologies Genome Editing Technologies Bioprocessing Technologies Other Technologies
Type of Product	Oligonucleotide / Oligo Pools and Synthetic DNA Enzymes Cloning Technologies Kits Chassis Organisms Other Products
Type of Application	Commercial Clinical
End-User	Biotechnology and Pharmaceutical Companies Academic and Government Research Institutes Other End-Users
Geographical Regions	North America Europe Asia-Pacific Latin America Middle East and Africa
Market in North America	US Canada
Market in Europe	Germany UK France Italy Spain
Market in Asia-Pacific	China Japan India Australia South Korea
Market in Latin America	Brazil Mexico Argentina
Market in Middle East and Africa	Saudi Arabia Israel UAE Egypt

In addition to synthetic biology’s expanding applications across various fields, the growing demand for early disease diagnosis and effective treatment drives significant investment in research and development for advanced genetic technologies. Notably, the growing research on cancer treatment development encourages the adoption of synthetic biology in the healthcare sector.

Your Business is Unique–Why Shouldn’t Your Report Be?

Market Share by Type of Technology: PCR Technologies Holds the Largest Share

In 2025, the PCR technologies segment will likely dominate the market (~30%). This stems from the fact that researchers widely use PCR technologies to diagnose infectious diseases and genetic disorders.
As per the market trends, the genome editing technologies sub-segment is likely to grow at a higher CAGR during the forecast period. Genome engineering drives this growth by enabling targeted and efficient DNA modifications, facilitating the development of advanced biological systems and therapeutics.

Market Share by Type of Product: Oligonucleotide / Oligo Pools and Synthetic DNA Dominates the Largest Share

In 2025, oligonucleotide/oligo pools and synthetic DNA will dominate the synthetic biology in healthcare market (~35%), driven by their cost-effectiveness, scalability, and versatility across applications such as gene synthesis, diagnostics, and therapeutics.
Enzymes segment shows remunerative growth potential, growing at a higher CAGR during the forecast period. This growth is due to the expanding use of enzymes in healthcare, including DNA manipulation, protein engineering, and biochemical processes.

Market Share by Type of Application: Commercial Applications Holds the Largest Share

In terms of applications, the global market is distributed across commercial and clinical applications. Commercial applications capture the majority of synthetic biology in healthcare market share (85%) in 2025.
This results from industries such as biotechnology, pharmaceuticals, healthcare, agriculture, and industrial biotechnology extensively using synthetic biology technologies. These sectors leverage synthetic biology for a wide range of high-value applications including drug discovery, vaccine development, gene therapy, personalized medicine, biopharmaceuticals, and biofuels production.

Market Share by End-User: Biotechnology and Pharmaceutical Companies Dominate the Synthetic Biology in Healthcare Market

There are various sub-segments of market based on end-user, such as biotechnology and pharmaceutical companies, academic and government research institutes and others. Growing demand for advanced therapies, such as monoclonal antibodies, gene therapies and personalized medicine will likely help biotechnology and pharmaceutical companies have highest synthetic biology market size.
The extensive use of synthetic biology by academic and government research institutes for applications such as developing biofuels, therapeutics, environmental bioremediation, and advanced agriculture will likely propel their segment to grow at a higher CAGR (14.9%) during the forecast period.

Market Share by Geographical Regions: North America to Propel in the Synthetic Biology in Healthcare Market in the Coming Years

Our synthetic biology in healthcare market forecast shows that North America will capture about 45% of the synthetic biology market, as strong public and private investments, supportive regulations, and significant funding initiatives propel regional growth.
Increased research activities in Asia-Pacific will accelerate market growth at a relatively faster pace in this region.

Want Information on Specific Region/Segment?

Synthetic Biology in Healthcare Market: Report Deliverables

Report Deliverables	Details
Excel Data Packs (Complimentary)	Market Landscape of Leading Players Market Forecast and Opportunity Analysis
Key Synthetic Biology Companies Profiled	BASF Codexis Eurofins Scientific GenScript Illumina Merck Precigen Thermo Fisher Scientific Agilent Technologies Bota Bio Creative Biogene Elevate Bio Ginkgo Bioworks New England Biolabs Synbio Technologies Synthego
PowerPoint Presentation (Complimentary)	Available
Customization Scope	15% Free Customization

Synthetic Biology in Healthcare Market Key Takeaways

The “Synthetic Biology in Healthcare Market: Industry Trends and Global Forecasts, till 2040” market report features an extensive study of the current market landscape of synthetic biology products and services providers, along with market value and future opportunities within the synthetic biology in healthcare market industry, during the forecast period.

Market Size Analysis: What is the Opportunity for Synthetic Biology Companies in Healthcare Industry?

The synthetic biology in healthcare market size is around USD 11.3 billion in 2025 and is expected to grow at a CAGR of 14.7% during the forecast period. In terms of type of technology, PCR technologies segment holds the largest share of the market.

It is worth highlighting that the genome editing technologies segment is growing at a CAGR of 15.5%. This can be attributed to the fact that genome editing technologies are driving advancements across fields such as medicine, agriculture, and biotechnology by enabling more precise, efficient, and affordable DNA modifications. They are increasingly being adopted due to their potential to treat genetic disorders, enhance crop resilience, and accelerate drug development, fueled by substantial government and private sector investments in research and innovation.

Regional Analysis: Which Region Holds the Largest Share of Synthetic Biology in Healthcare Market?

North America is Leading the Market

In 2040, North America’s market will likely dominate, capturing around 45% of the market share. Key factors that contribute to the region’s dominance in this industry include the substantial investments, favorable regulatory environments, and increased government support.

Asia-Pacific: An Emerging Growth Spot

As per synthetic biology in healthcare market analysis, the market in Asia-Pacific is likely to grow at a CAGR of 15.6% in the forecast period. Declining costs of DNA sequencing and synthesis, along with growing awareness and demand for synthetic biology applications in pharmaceuticals, biotechnology, biofuels, and other industrial sectors in countries like China, primarily drive this growth.

What are the Key Drivers of Synthetic Biology in Healthcare Market?

Advancements in biotechnology and genetic engineering, such as gene editing tools and CRISPR-Cas9, are propelling the growth of synthetic biology in healthcare. These technologies enable the modification of microbial genes with higher precision. This precision allows researchers to develop personalized gene therapies targeting a broad range of diseases including cancer, sickle cell anemia and cystic fibrosis.

Moreover, the growing shift towards biomanufacturing for developing a wide variety of products across different industrial verticals has further accelerated the synthetic biology in healthcare market growth.

Unlock Deeper Insights–Schedule Your Personalized Workshop Today!

Synthetic Biology in Healthcare Market Report Coverage

An Infographic Executive Summary
Market Landscape of Leading Synthetic Biology Product and Service Providers
Market Impact Analysis
Market Forecast Analysis
Mega Trends Analysis
Porter’s Five Forces Analysis
Company Profiles

From the Author’s Desk

Author’s View on Synthetic Biology in Healthcare Market

The rise of synthetic biology techniques, such as gene editing and metabolic engineering, has drawn significant interest from researchers and industry leaders. They see its potential to create novel biological functions, enhance sustainability, and address healthcare, agricultural, and environmental challenges. As a result, experts expect synthetic biology adoption to accelerate rapidly.

About Authors

Lead Author: Vaibhav Singh

Lead Reviewer: Rupanshi Sharma

Chief Editor: Prachi Bhalla

Glossary

Synthetic Biology: Synthetic biology is an interdisciplinary field that involves designing and constructing new biological parts, devices, and systems, or redesigning existing natural biological systems for useful purposes.
Oligonucleotide: An oligonucleotide is a short strand of DNA or RNA, typically composed of a small number of nucleotides linked together.
Cloning Technologies Kits: Cloning technology kits comprises of reagents and tools designed to quickly and efficiently insert DNA fragments into vectors for replication and study in molecular biology applications.
Chassis Organisms: Chassis organisms are standardized, engineered biological platforms used in synthetic biology to host and support new genetic components or functions.
CRISPR-Cas9: CRISPR-Cas9 is a precise, RNA-guided gene-editing technology that enables targeted modification of an organism's DNA by cutting and altering specific genetic sequences.

+ 1. PREFACE

1.1. Introduction

1.2. Market Share Insights

1.3. Key Market Insights

1.4. Report Coverage

1.5. Key Questions Answered

1.6. Chapter Outlines

+ 2. RESEARCH METHODOLOGY

2.1. Chapter Overview

2.2. Research Assumptions

2.2.1. Market Landscape and Market Trends

2.2.2. Market Forecast and Opportunity Analysis

2.2.3. Comparative Analysis

2.3. Database Building

2.3.1. Data Collection

2.3.2. Data Validation

2.3.3. Data Analysis

2.4. Project Methodology

2.4.1. Secondary Research

2.4.1.1. Annual Reports

2.4.1.2. Academic Research Papers

2.4.1.3. Company Websites

2.4.1.4. Investor Presentations

2.4.1.5. Regulatory Filings

2.4.1.6. White Papers

2.4.1.7. Industry Publications

2.4.1.8. Conferences and Seminars

2.4.1.9. Government Portals

2.4.1.10. Media and Press Releases

2.4.1.11. Newsletters

2.4.1.12. Industry Databases

2.4.1.13. Roots Proprietary Databases

2.4.1.14. Paid Databases and Sources

2.4.1.15. Social Media Portals

2.4.1.16. Other Secondary Sources

2.4.2. Primary Research

2.4.2.1. Types of Primary Research

2.4.2.1.1. Qualitative Research

2.4.2.1.2. Quantitative Research

2.4.2.1.3. Hybrid Approach

2.4.2.2. Advantages of Primary Research

2.4.2.3. Techniques for Primary Research

2.4.2.3.1. Interviews

2.4.2.3.2. Surveys

2.4.2.3.3. Focus Groups

2.4.2.3.4. Observational Research

2.4.2.3.5. Social Media Interactions

2.4.2.4. Key Opinion Leaders Considered in Primary Research

2.4.2.4.1. Company Executives (CXOs)

2.4.2.4.2. Board of Directors

2.4.2.4.3. Company Presidents and Vice Presidents

2.4.2.4.4. Research and Development Heads

2.4.2.4.5. Technical Experts

2.4.2.4.6. Subject Matter Experts

2.4.2.4.7. Scientists

2.4.2.4.8. Doctors and Other Healthcare Providers

2.4.2.5. Ethics and Integrity

2.4.2.5.1. Research Ethics

2.4.2.5.2. Data Integrity

2.4.3. Analytical Tools and Databases

2.5. Robust Quality Control

+ 3. MARKET DYNAMICS

3.1. Chapter Overview

3.2. Forecast Methodology

3.2.1. Top-down Approach

3.2.2. Bottom-up Approach

3.2.3. Hybrid Approach

3.3. Market Assessment Framework

3.3.1. Total Addressable Market (TAM)

3.3.2. Serviceable Addressable Market (SAM)

3.3.3. Serviceable Obtainable Market (SOM)

3.3.4. Currently Acquired Market (CAM)

3.4. Forecasting Tools and Techniques

3.4.1. Qualitative Forecasting

3.4.2. Correlation

3.4.3. Regression

3.4.4. Extrapolation

3.4.5. Convergence

3.4.6. Sensitivity Analysis

3.4.7. Scenario Planning

3.4.8. Data Visualization

3.4.9. Time Series Analysis

3.4.10. Forecast Error Analysis

3.5. Key Considerations

3.5.1. Demographics

3.5.2. Government Regulations

3.5.3. Reimbursement Scenarios

3.5.4. Market Access

3.5.5. Supply Chain

3.5.6. Industry Consolidation

3.5.7. Pandemic / Unforeseen Disruptions Impact

3.6. Limitations

+ 4. MACRO-ECONOMIC INDICATORS

4.1. Chapter Overview

4.2. Market Dynamics

4.2.1. Time Period

4.2.1.1. Historical Trends

4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage

4.2.2.1. Major Currencies Affecting the Market

4.2.2.2. Factors Affecting Currency Fluctuations

4.2.2.3. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Currency Exchange Rate

4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market

4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession

4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt

4.2.5. Inflation

4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy

4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates

4.2.6.1. Interest Rates and Their Impact on the Market

4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis

4.2.7.1. Type of Commodity

4.2.7.2. Origins and Destinations

4.2.7.3. Values and Weights

4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics

4.2.8.1. Import Scenario

4.2.8.2. Export Scenario

4.2.8.3. Trade Policies

4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers

4.2.8.5. Impact of Trade Barriers on the Market

4.2.9. War Impact Analysis

4.2.9.1. Russian-Ukraine War

4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors

4.2.10.1. Global Economic Impact

4.2.10.2. Industry-specific Impact

4.2.10.3. Government Response and Stimulus Measures

4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators

4.2.11.1. Fiscal Policy

4.2.11.2. Consumer Spending

4.2.11.3. Gross Domestic Product (GDP)

4.2.11.4. Employment

4.2.11.5. Taxes

4.2.11.6. Stock Market Performance

4.2.11.7. Cross-Border Dynamics

4.3. Conclusion

+ 5. EXECUTIVE SUMMARY

+ 6. INTRODUCTION

6.1. Chapter Overview

6.2. Overview of Synthetic Biology

6.3. Classification of Synthetic Biology

6.4. Advantages of Synthetic Biology

6.5. Key Application of Synthetic Biology

6.6. Future Perspectives of Synthetic Biology

+ 7. MARKET LANDSCAPE: LEADING SYNTHETIC BIOLOGY PRODUCTS AND SERVICES PROVIDERS

7.1. Chapter Overview

7.2. Leading Synthetic Biology Products and Services Providers: Overall Market Landscape

7.2.1. Analysis by Year of Establishment

7.2.2. Analysis by Company Size

7.2.3. Analysis by Location of Headquarters

7.2.4. Analysis by Type of Product

7.2.5. Analysis by Type of Technique / Technology Used

7.2.6. Analysis by Type of Application

7.2.7. Analysis by End-User

+ 8. MARKET IMPACT ANALYSIS

+ 9. SYNTHETIC BIOLOGY IN HEALTHCARE MARKET

9.1. Chapter Overview

9.2. Assumptions and Methodology

9.3. Synthetic Biology in Healthcare Market, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

9.3.1. Scenario Analysis

9.3.1.1. Conservative Scenario

9.3.1.2. Optimistic Scenario

9.4. Key Market Segmentations

+ 10. SYNTHETIC BIOLOGY IN HEALTHCARE MARKET, BY TYPE OF TECHNOLOGY

10.1. Chapter Overview

10.2. Key Assumptions and Methodology

10.3. Synthetic Biology in Healthcare Market: Distribution by Type of Technology

10.3.1. Synthetic Biology in Healthcare Market for PCR Technologies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

10.3.2. Synthetic Biology in Healthcare Market for NGS Technologies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

10.3.3. Synthetic Biology in Healthcare Market for Genome Editing Technologies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

10.3.4. Synthetic Biology in Healthcare Market for Bioprocessing Technologies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

10.3.5. Synthetic Biology in Healthcare Market for Other Technologies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

10.4. Data Triangulation and Validation

+ 11. SYNTHETIC BIOLOGY IN HEALTHCARE MARKET, BY TYPE OF PRODUCT

11.1. Chapter Overview

11.2. Key Assumptions and Methodology

11.3. Synthetic Biology in Healthcare Market: Distribution by Type of Prodcut

11.3.1. Synthetic Biology in Healthcare Market for Oligonucleotide / Oligo Pools and Synthetic DNA, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

11.3.2. Synthetic Biology in Healthcare Market for Enzymes, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

11.3.3. Synthetic Biology in Healthcare Market for Cloning Technologies Kits, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

11.3.4. Synthetic Biology in Healthcare Market for Chassis Organisms, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

11.3.5. Synthetic Biology in Healthcare Market for Other Products, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

11.4. Data Triangulation and Validation

+ 12. SYNTHETIC BIOLOGY IN HEALTHCARE MARKET, BY TYPE OF APPLICATION

12.1. Chapter Overview

12.2. Key Assumptions and Methodology

12.3. Synthetic Biology in Healthcare Market: Distribution by Type of Application

12.3.1. Synthetic Biology in Healthcare Market for Commercial Applications, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

12.3.2. Synthetic Biology in Healthcare Market for Clinical Applications, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

12.4. Data Triangulation and Validation

+ 13. SYNTHETIC BIOLOGY IN HEALTHCARE MARKET, BY END-USER

13.1. Chapter Overview

13.2. Key Assumptions and Methodology

13.3. Synthetic Biology in Healthcare Market: Distribution by End-User

13.3.1. Synthetic Biology in Healthcare Market for Biotechnology and Pharmaceutical Companies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

13.3.2. Synthetic Biology in Healthcare Market for Academic and Government Research Institutes, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

13.3.3. Synthetic Biology in Healthcare Market for Others, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

13.4. Data Triangulation and Validation

+ 14. SYNTHETIC BIOLOGY IN HEALTHCARE MARKET, BY GEOGRAPHICAL REGIONS

14.1. Chapter Overview

14.2. Key Assumptions and Methodology

14.3. Synthetic Biology in Healthcare Market: Distribution by Geographical Regions

14.3.1. Synthetic Biology in Healthcare Market in North America, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.1.1. Synthetic Biology in Healthcare Market in the US, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.1.2. Synthetic Biology in Healthcare Market in Canada, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.2. Synthetic Biology in Healthcare Market in Europe, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.2.1. Synthetic Biology in Healthcare Market in Germany, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.2.2. Synthetic Biology in Healthcare Market in the UK, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.2.3. Synthetic Biology in Healthcare Market in France, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.2.4. Synthetic Biology in Healthcare Market in Italy, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.2.5. Synthetic Biology in Healthcare Market in Spain, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.3. Synthetic Biology in Healthcare Market in Aisa-Pacific, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.3.1. Synthetic Biology in Healthcare Market in China, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.3.2. Synthetic Biology in Healthcare Market in Japan, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.3.3. Synthetic Biology in Healthcare Market in India, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.3.4. Synthetic Biology in Healthcare Market in Australia, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.3.5. Synthetic Biology in Healthcare Market in South Korea, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.4. Synthetic Biology in Healthcare Market in Latin America, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.4.1. Synthetic Biology in Healthcare Market in Brazil, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.4.2. Synthetic Biology in Healthcare Market in Mexico, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.4.3. Synthetic Biology in Healthcare Market in Argentina, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.5. Synthetic Biology in Healthcare Market in Middle East and Africa, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.5.1. Synthetic Biology in Healthcare Market in Saudi Arabia, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.5.2. Synthetic Biology in Healthcare Market in Israel, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.5.3. Synthetic Biology in Healthcare Market in UAE, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

14.3.5.4. Synthetic Biology in Healthcare Market in Egypt, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040)

+ 15. MEGATRENDS ANALYSIS

+ 16. PORTER’S FIVE FORCES ANALYSIS

+ 17. COMPANY PROFILES: LEADING PLAYERS IN THE SYNTHETIC BIOLOGY MARKET

17.1. Chapter Overview

17.2. BASF

17.2.1. Company Overview

17.2.2. Synthetic Biology Product Portfolio

17.2.3. Financial Information

17.2.4. Recent Developments and Future Outlook

17.3. Codexis

17.3.1. Company Overview

17.3.2. Synthetic Biology Product Portfolio

17.3.3. Financial Information

17.3.4. Recent Developments and Future Outlook

17.4. Eurofins Scientific

17.4.1. Company Overview

17.4.2. Synthetic Biology Product Portfolio

17.4.3. Financial Information

17.4.4. Recent Developments and Future Outlook

17.5. GenScript

17.5.1. Company Overview

17.5.2. Synthetic Biology Product Portfolio

17.5.3. Financial Information

17.5.4. Recent Developments and Future Outlook

17.6. Illumina

17.6.1. Company Overview

17.6.2. Synthetic Biology Product Portfolio

17.6.3. Financial Information

17.6.4. Recent Developments and Future Outlook

17.7. Merck

17.7.1. Company Overview

17.7.2. Synthetic Biology Product Portfolio

17.7.3. Financial Information

17.7.4. Recent Developments and Future Outlook

17.8. Precigen

17.8.1. Company Overview

17.8.2. Synthetic Biology Product Portfolio

17.8.3. Financial Information

17.8.4. Recent Developments and Future Outlook

17.9. Thermo Fisher Scientific

17.9.1. Company Overview

17.9.2. Synthetic Biology Product Portfolio

17.9.3. Financial Information

17.9.4. Recent Developments and Future Outlook

+ 18. COMPANY PROFILES: OTHER LEADING PLAYERS IN THE SYNTHETIC BIOLOGY MARKET

18.1. Chapter Overview

18.2. Agilent Technologies

18.2.1. Company Overview

18.2.2. Synthetic Biology Product Portfolio

18.3. Bota Bio

18.3.1. Company Overview

18.3.2. Synthetic Biology Product Portfolio

18.4. Creative Biogene

18.4.1. Company Overview

18.4.2. Synthetic Biology Product Portfolio

18.5. Elevate Bio

18.5.1. Company Overview

18.5.2. Synthetic Biology Product Portfolio

18.6. Ginkgo Bioworks

18.6.1. Company Overview

18.6.2. Synthetic Biology Product Portfolio

18.7. New England Biolabs

18.7.1. Company Overview

18.7.2. Synthetic Biology Product Portfolio

18.8. Synbio Technologies

18.8.1. Company Overview

18.8.2. Synthetic Biology Product Portfolio

18.9. Synthego

18.9.1. Company Overview

18.9.2. Synthetic Biology Product Portfolio

+ 19. APPENDIX 1: TABULATED DATA

+ 20. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIO

+ List of Figures

Figure 2.1 Research Methodology: Project Methodology

Figure 2.2 Research Methodology: Data Sources for Secondary Research

Figure 2.3 Research Methodology: Robust Quality Control

Figure 3.1 Market Dynamics: Forecast Methodology

Figure 3.2 Market Dynamics: Market Assessment Framework

Figure 4.1 Lessons Learnt from Past Recessions

Figure 5.1 Executive Summary: Market Landscape

Figure 5.2 Executive Summary: Market Sizing and Opportunity Analysis

Figure 6.1 Classification of Synthetic Biology

Figure 7.1 Leading Synthetic Biology Products and Services Providers: Distribution by Year of Establishment

Figure 7.2 Leading Synthetic Biology Products and Services Providers: Distribution by Company Size

Figure 7.3 Leading Synthetic Biology Products and Services Providers: Distribution by Location of Headquarters

Figure 7.4 Leading Synthetic Biology Products and Services Providers: Distribution by Type of Product

Figure 7.5 Leading Synthetic Biology Products and Services Providers: Distribution by Type of Technique / Technology Used

Figure 7.6 Leading Synthetic Biology Products and Services Providers: Distribution by Type of Application

Figure 7.7 Leading Synthetic Biology Products and Services Providers: Distribution by End-User

Figure 8.1 Synthetic Biology Products and Services: Growth Drivers

Figure 8.2 Synthetic Biology Products and Services: Market Restraints

Figure 8.3 Synthetic Biology Products and Services: Opportunities

Figure 8.4 Synthetic Biology Products and Services: Challenges

Figure 9.1 Synthetic Biology Market in Healthcare, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 9.2 Synthetic Biology Market in Healthcare, Forecasted Estimates (Till 2040): Conservative Scenario (USD Million)

Figure 9.3 Synthetic Biology Market in Healthcare, Forecasted Estimates (Till 2040): Optimistic Scenario (USD Million)

Figure 10.1 Synthetic Biology Market in Healthcare: Distribution by Type of Technology, 2020, 2025 and 2040

Figure 10.2 Synthetic Biology Market in Healthcare for PCR Technologies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 10.3 Synthetic Biology Market in Healthcare for NGS Technologies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 10.4 Synthetic Biology Market in Healthcare for Genome Editing Technologies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 10.5 Synthetic Biology Market in Healthcare for Bioprocessing Technologies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 10.6 Synthetic Biology Market in Healthcare for Other Technologies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 11.1 Synthetic Biology Market in Healthcare: Distribution by Type of Product, 2020, 2025 and 2040

Figure 11.2 Synthetic Biology Market in Healthcare for Oligonucleotide / Oligo Pools and Synthetic DNA, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 11.3 Synthetic Biology Market in Healthcare for Enzymes, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 11.4 Synthetic Biology Market in Healthcare for Cloning Technologies Kits, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 11.5 Synthetic Biology Market in Healthcare for Chassis Organisms, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 11.6 Synthetic Biology Market in Healthcare for Other Products, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 12.1 Synthetic Biology Market in Healthcare: Distribution by Type of Application, 2020, 2025 and 2040

Figure 12.2 Synthetic Biology Market in Healthcare for Commercial Applications, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 12.3 Synthetic Biology Market in Healthcare for Clinical Applications, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 13.1 Synthetic Biology Market in Healthcare: Distribution by End-User, 2020, 2025 and 2040

Figure 13.2 Synthetic Biology Market in Healthcare for Biotechnology and Pharmaceutical Companies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 13.3 Synthetic Biology Market in Healthcare for Academic and Government Research Institutes, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 13.4 Synthetic Biology in Healthcare Market for Others, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.1 Synthetic Biology in Healthcare Market: Distribution by Geographical Regions, 2020, 2025 and 2040

Figure 14.2 Synthetic Biology in Healthcare Market in North America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.3 Synthetic Biology in Healthcare Market in the US: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.4 Synthetic Biology in Healthcare Market in Canada: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.5 Synthetic Biology in Healthcare Market in Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.6 Synthetic Biology in Healthcare Market in Germany: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.7 Synthetic Biology in Healthcare Market in the UK: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.8 Synthetic Biology in Healthcare Market in France: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.9 Synthetic Biology in Healthcare Market in Italy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.10 Synthetic Biology in Healthcare Market in Spain: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.11 Synthetic Biology in Healthcare Market in Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.12 Synthetic Biology in Healthcare Market in China: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.13 Synthetic Biology in Healthcare Market in Japan: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.14 Synthetic Biology in Healthcare Market in India: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.15 Synthetic Biology in Healthcare Market in Australia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.16 Synthetic Biology in Healthcare Market in South Korea: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.17 Synthetic Biology in Healthcare Market in Latin America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.18 Synthetic Biology in Healthcare Market in Brazil: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.19 Synthetic Biology in Healthcare Market in Mexico: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.20 Synthetic Biology in Healthcare Market in Argentina: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.21 Synthetic Biology in Healthcare Market in Middle East and Africa: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.22 Synthetic Biology in Healthcare Market in Saudi Arabia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.23 Synthetic Biology in Healthcare Market in Israel: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.24 Synthetic Biology in Healthcare Market in UAE: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 14.25 Synthetic Biology in Healthcare Market in Egypt: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Figure 15.1 Megatrends Analysis: An overview of the Emerging Trends

Figure 17.1 BASF: Business Segment-wise Revenues (EUR Million)

Figure 17.2 Codexis: Business Segment-wise Revenues (USD Million)

Figure 17.3 Eurofins Scientific: Business Segment-wise Revenues (EUR Million)

Figure 17.4 GenScript: Business Segment-wise Revenues (USD Million)

Figure 17.5 Illumina: Business Segment-wise Revenues (USD Million)

Figure 17.6 Merck: Business Segment-wise Revenues (USD Million)

Figure 17.7 Precigen: Business Segment-wise Revenues (USD Million)

Figure 17.8 Thermo Fisher Scientific: Business Segment-wise Revenues (USD Million)

List of Companies

Agilent Technologies

Amyris

ATUM

BASF

Bota Bio

Codexis

Creative Biogene

Cyrus Biotechnology

DNAstar

Elevate Bio

Eurofins Scientific

GenScript

Ginkgo Bioworks

Illumina

Inscripta

Integrated DNA Technologies

Merck

New England Biolabs

Precigen

Scarab Genomics

Synbio Technologies

Synthego

Teselagen

Thermo Fisher Scientific

Zenfold

+ List of Tables

Table 7.1 List of Leading Synthetic Biology Products and Services Providers

Table 7.2 Leading Synthetic Biology Products and Services Providers: Information on Type of Product, Type of Technique / Technology Used, Type of Application and End-User

Table 17.1 BASF: Synthetic Biology Products and Services Portfolio

Table 17.2 Codexis: Synthetic Biology Products and Services Portfolio

Table 17.3 Eurofins Scientific: Synthetic Biology Products and Services Portfolio

Table 17.4 GenScript: Synthetic Biology Products and Services Portfolio

Table 17.5 Illumina: Synthetic Biology Products and Services Portfolio

Table 17.6 Merck: Synthetic Biology Products and Services Portfolio

Table 17.7 Precigen: Synthetic Biology Products and Services Portfolio

Table 17.8 Thermo Fisher Scientific: Synthetic Biology Products and Services Portfolio

Table 18.1 Agilent Technologies: Synthetic Biology Products and Services Portfolio

Table 18.2 Bota Bio: Synthetic Biology Products and Services Portfolio

Table 18.3 Creative Biogene: Synthetic Biology Products and Services Portfolio

Table 18.4 Elevate Bio: Synthetic Biology Products and Services Portfolio

Table 18.5 Ginkgo Bioworks: Synthetic Biology Products and Services Portfolio

Table 18.6 New England Biolabs: Synthetic Biology Products and Services Portfolio

Table 18.7 Synbio Technologies: Synthetic Biology Products and Services Portfolio

Table 18.8 Synthego: Synthetic Biology Products and Services Portfolio

Table 19.1 Leading Synthetic Biology Products and Services Providers: Distribution by Year of Establishment

Table 19.2 Leading Synthetic Biology Products and Services Providers: Distribution by Company Size

Table 19.3 Leading Synthetic Biology Products and Services Providers: Distribution by Location of Headquarters

Table 19.4 Leading Synthetic Biology Products and Services Providers: Distribution by Type of Product

Table 19.5 Leading Synthetic Biology Products and Services Providers: Distribution by Type of Technique / Technology Used

Table 19.6 Leading Synthetic Biology Products and Services Providers: Distribution by Type of Application

Table 19.7 Leading Synthetic Biology Products and Services Providers: Distribution by End-User

Table 19.8 Synthetic Biology Market in Healthcare, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.9 Synthetic Biology Market in Healthcare, Forecasted Estimates (Till 2040): Conservative Scenario (USD Million)

Table 19.10 Synthetic Biology Market in Healthcare, Forecasted Estimates (Till 2040): Optimistic Scenario (USD Million)

Table 19.11 Synthetic Biology Market in Healthcare: Distribution by Type of Technology, 2020, 2025 and 2040

Table 19.12 Synthetic Biology Market in Healthcare for PCR Technologies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.13 Synthetic Biology Market in Healthcare for NGS Technologies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.14 Synthetic Biology Market in Healthcare for Genome Editing Technologies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.15 Synthetic Biology Market in Healthcare for Bioprocessing Technologies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.16 Synthetic Biology Market in Healthcare for Other Technologies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.17 Synthetic Biology Market in Healthcare: Distribution by Type of Product, 2020, 2025 and 2040

Table 19.18 Synthetic Biology Market in Healthcare for Oligonucleotide / Oligo Pools and Synthetic DNA, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.19 Synthetic Biology Market in Healthcare for Enzymes, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.20 Synthetic Biology Market in Healthcare for Cloning Technologies Kits, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.21 Synthetic Biology Market in Healthcare for Chassis Organisms, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.22 Synthetic Biology Market in Healthcare for Other Products, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.23 Synthetic Biology Market in Healthcare: Distribution by Type of Application, 2020, 2025 and 2040

Table 19.24 Synthetic Biology Market in Healthcare for Commercial Applications, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.25 Synthetic Biology Market in Healthcare for Clinical Applications, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.26 Synthetic Biology Market in Healthcare: Distribution by End-User, 2020, 2025 and 2040

Table 19.27 Synthetic Biology Market in Healthcare for Biotechnology and Pharmaceutical Companies, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.28 Synthetic Biology Market in Healthcare for Academic and Government Research Institutes, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.29 Synthetic Biology in Healthcare Market for Others, Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.30 Synthetic Biology in Healthcare Market: Distribution by Geographical Regions, 2020, 2025 and 2040

Table 19.31 Synthetic Biology in Healthcare Market in North America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.32 Synthetic Biology in Healthcare Market in the US: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.33 Synthetic Biology in Healthcare Market in Canada: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.34 Synthetic Biology in Healthcare Market in Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.35 Synthetic Biology in Healthcare Market in Germany: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.36 Synthetic Biology in Healthcare Market in the UK: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.37 Synthetic Biology in Healthcare Market in France: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.38 Synthetic Biology in Healthcare Market in Italy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.39 Synthetic Biology in Healthcare Market in Spain: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.40 Synthetic Biology in Healthcare Market in Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.41 Synthetic Biology in Healthcare Market in China: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.42 Synthetic Biology in Healthcare Market in Japan: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.43 Synthetic Biology in Healthcare Market in India: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.44 Synthetic Biology in Healthcare Market in Australia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.45 Synthetic Biology in Healthcare Market in South Korea: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.46 Synthetic Biology in Healthcare Market in Latin America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.47 Synthetic Biology in Healthcare Market in Brazil: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.48 Synthetic Biology in Healthcare Market in Mexico: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.49 Synthetic Biology in Healthcare Market in Argentina: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.50 Synthetic Biology in Healthcare Market in Middle East and Africa: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.51 Synthetic Biology in Healthcare Market in Saudi Arabia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.52 Synthetic Biology in Healthcare Market in Israel: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.53 Synthetic Biology in Healthcare Market in UAE: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.54 Synthetic Biology in Healthcare Market in Egypt: Historical Trends (Since 2020) and Forecasted Estimates (Till 2040) (USD Million)

Table 19.55 BASF: Business Segment-wise Revenues (EUR Million)

Table 19.56 Codexis: Business Segment-wise Revenues (USD Million)

Table 19.57 Eurofins Scientific: Business Segment-wise Revenues (EUR Million)

Table 19.58 GenScript: Business Segment-wise Revenues (USD Million)

Table 19.59 Illumina: Business Segment-wise Revenues (USD Million)

Table 19.60 Merck: Business Segment-wise Revenues (USD Million)

Table 19.61 Precigen: Business Segment-wise Revenues (USD Million)

Table 19.62 Thermo Fisher Scientific: Business Segment-wise Revenues (USD Million)

+ List of Companies and Organizations

Please reach out to our team for more details.

Synthetic Biology in Healthcare Market

Global Synthetic Biology in Healthcare Market Size

Synthetic Biology in Healthcare Market: Report Attributes

Recent Developments in Synthetic Biology in Healthcare Market

Advances in Laboratory-Based Human Embryo Models

Synthetic Biology in Healthcare Market Segmentation Insights

Synthetic Biology in Healthcare Market: Market Segmentation

Market Share by Type of Technology: PCR Technologies Holds the Largest Share

Market Share by Type of Product: Oligonucleotide / Oligo Pools and Synthetic DNA Dominates the Largest Share

Market Share by Type of Application: Commercial Applications Holds the Largest Share

Market Share by End-User: Biotechnology and Pharmaceutical Companies Dominate the Synthetic Biology in Healthcare Market

Market Share by Geographical Regions: North America to Propel in the Synthetic Biology in Healthcare Market in the Coming Years

Synthetic Biology in Healthcare Market: Report Deliverables

Synthetic Biology in Healthcare Market Key Takeaways

Market Size Analysis: What is the Opportunity for Synthetic Biology Companies in Healthcare Industry?

Regional Analysis: Which Region Holds the Largest Share of Synthetic Biology in Healthcare Market?

North America is Leading the Market

Asia-Pacific: An Emerging Growth Spot

What are the Key Drivers of Synthetic Biology in Healthcare Market?

Synthetic Biology in Healthcare Market Report Coverage

From the Author’s Desk

Author’s View on Synthetic Biology in Healthcare Market

About Authors

Glossary

Table of Contents

The Future of Autonomous Deliveries: Integrating Drones and Self-Driving Vehicles

Radiopharmaceutical Manufacturing: A Multi-Disciplinary Endeavour for Medical Imaging and Interventional Treatment

Synthetic Biology in Healthcare Market

Global Synthetic Biology in Healthcare Market Size

Synthetic Biology in Healthcare Market: Report Attributes

Recent Developments in Synthetic Biology in Healthcare Market

Advances in Laboratory-Based Human Embryo Models

Synthetic Biology in Healthcare Market Segmentation Insights

Synthetic Biology in Healthcare Market: Market Segmentation

Synthetic Biology in Healthcare Market Share Insights

Market Share by Type of Technology: PCR Technologies Holds the Largest Share

Market Share by Type of Product: Oligonucleotide / Oligo Pools and Synthetic DNA Dominates the Largest Share

Market Share by Type of Application: Commercial Applications Holds the Largest Share

Market Share by End-User: Biotechnology and Pharmaceutical Companies Dominate the Synthetic Biology in Healthcare Market

Market Share by Geographical Regions: North America to Propel in the Synthetic Biology in Healthcare Market in the Coming Years

Synthetic Biology in Healthcare Market: Report Deliverables

Synthetic Biology in Healthcare Market Key Takeaways

Market Size Analysis: What is the Opportunity for Synthetic Biology Companies in Healthcare Industry?

Regional Analysis: Which Region Holds the Largest Share of Synthetic Biology in Healthcare Market?

North America is Leading the Market

Asia-Pacific: An Emerging Growth Spot

What are the Key Drivers of Synthetic Biology in Healthcare Market?

Synthetic Biology in Healthcare Market Report Coverage

From the Author’s Desk

Author’s View on Synthetic Biology in Healthcare Market

About Authors

Glossary

Table of Contents

The Future of Autonomous Deliveries: Integrating Drones and Self-Driving Vehicles

Radiopharmaceutical Manufacturing: A Multi-Disciplinary Endeavour for Medical Imaging and Interventional Treatment